| Endothelial-to-mesenchymal transition in pulmonary hypertension B Ranchoux, F Antigny, C Rucker-Martin, A Hautefort, C Péchoux, ... Circulation 131 (11), 1006-1018, 2015 | 526 | 2015 |
| Chemotherapy-induced pulmonary hypertension: role of alkylating agents B Ranchoux, S Günther, R Quarck, MC Chaumais, P Dorfmüller, F Antigny, ... The American journal of pathology 185 (2), 356-371, 2015 | 197 | 2015 |
| Potassium channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension F Antigny, A Hautefort, J Meloche, M Belacel-Ouari, B Manoury, ... Circulation 133 (14), 1371-1385, 2016 | 180 | 2016 |
| Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension F Perros, B Ranchoux, M Izikki, S Bentebbal, C Happé, F Antigny, ... Journal of the American College of Cardiology 65 (7), 668-680, 2015 | 159 | 2015 |
| Evidence for the involvement of type I interferon in pulmonary arterial hypertension PM George, E Oliver, P Dorfmuller, OD Dubois, DM Reed, NS Kirkby, ... Circulation research 114 (4), 677-688, 2014 | 142 | 2014 |
| Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models F Perros, S Günther, B Ranchoux, L Godinas, F Antigny, MC Chaumais, ... Circulation 132 (9), 834-847, 2015 | 129 | 2015 |
| miR-223 reverses experimental pulmonary arterial hypertension J Meloche, M Le Guen, F Potus, J Vinck, B Ranchoux, I Johnson, ... American Journal of Physiology-Cell Physiology 309 (6), C363-C372, 2015 | 125 | 2015 |
| Transient receptor potential canonical channels are required for in vitro endothelial tube formation F Antigny, N Girardin, M Frieden Journal of Biological Chemistry 287 (8), 5917-5927, 2012 | 102 | 2012 |
| Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension A Hautefort, P Mendes-Ferreira, J Sabourin, G Manaud, T Bertero, ... Circulation 139 (7), 932-948, 2019 | 95 | 2019 |
| NMDA-type glutamate receptor activation promotes vascular remodeling and pulmonary arterial hypertension SJ Dumas, G Bru-Mercier, A Courboulin, M Quatredeniers, ... Circulation 137 (22), 2371-2389, 2018 | 94 | 2018 |
| Potassium channels in pulmonary arterial hypertension O Boucherat, S Chabot, F Antigny, F Perros, S Provencher, S Bonnet European Respiratory Journal 46 (4), 1167-1177, 2015 | 90 | 2015 |
| Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR F Antigny, C Norez, F Becq, C Vandebrouck Cell calcium 43 (2), 175-183, 2008 | 90 | 2008 |
| Maintaining Low Ca2+ Level in the Endoplasmic Reticulum Restores Abnormal Endogenous F508del‐CFTR Trafficking in Airway Epithelial Cells C Norez, F Antigny, F Becq, C Vandebrouck Traffic 7 (5), 562-573, 2006 | 89 | 2006 |
| Transient receptor potential canonical (TRPC)/Orai1-dependent store-operated Ca2+ channels: new targets of aldosterone in cardiomyocytes J Sabourin, F Bartoli, F Antigny, AM Gomez, JP Benitah Journal of Biological Chemistry 291 (25), 13394-13409, 2016 | 88 | 2016 |
| Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension M Lambert, V Capuano, A Boet, L Tesson, T Bertero, MK Nakhleh, ... Circulation research 125 (7), 678-695, 2019 | 86 | 2019 |
| Ca2+ handling remodeling and STIM1L/Orai1/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy J Sabourin, A Boet, C Rucker-Martin, M Lambert, AM Gomez, JP Benitah, ... Journal of molecular and cellular cardiology 118, 208-224, 2018 | 78 | 2018 |
| A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non–cystic fibrosis–like phenotype C Norez, F Antigny, S Noel, C Vandebrouck, F Becq American journal of respiratory cell and molecular biology 41 (2), 217-225, 2009 | 77 | 2009 |
| Thapsigargin activates Ca2+ entry both by store-dependent, STIM1/Orai1-mediated, and store-independent, TRPC3/PLC/PKC-mediated pathways in human endothelial cells F Antigny, H Jousset, S König, M Frieden Cell calcium 49 (2), 115-127, 2011 | 76 | 2011 |
| Ion channels in pulmonary hypertension: a therapeutic interest? M Lambert, V Capuano, A Olschewski, J Sabourin, C Nagaraj, B Girerd, ... International journal of molecular sciences 19 (10), 3162, 2018 | 75 | 2018 |
| CFTR and Ca2+ signaling in cystic fibrosis F Antigny, C Norez, F Becq, C Vandebrouck Frontiers in pharmacology 2, 13934, 2011 | 70 | 2011 |
David MONTANIProfessor of Respiratory Medicine, Université Paris–Saclay, AP-HP, INSERM UMR_S 999, Service deVerified email at aphp.fr
